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Dicarboxylic acids are important bio-based building blocks, and Saccharomyces cere-
visiae is postulated to be an advantageous host for their fermentative production. Here,
we engineered a pyruvate decarboxylase-negative S. cerevisiae strain for succinic acid
production to exploit its promising properties, that is, lack of ethanol production and
accumulation of the precursor pyruvate. The metabolic engineering steps included
genomic integration of a biosynthesis pathway based on the reductive branch of the
tricarboxylic acid cycle and a dicarboxylic acid transporter. Further modifications
were the combined deletion of GPD1 and FUM1 and multi-copy integration of the
native PYC2 gene, encoding a pyruvate carboxylase required to drain pyruvate into
the synthesis pathway. The effect of increased redox cofactor supply was tested by
modulating oxygen limitation and supplementing formate. The physiologic analysis
of the differently engineered strains focused on elucidatingmetabolic bottlenecks. The
data not only highlight the importance of a balanced activity of pathway enzymes and
selective export systems but also shows the importance to find an optimal trade-off
between redox cofactor supply and energy availability in the form of ATP.
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1 INTRODUCTION
Organic acids are industrially essential chemicals that are pro-
duced annually on a multi-million-ton scale for use in the
food, pharmaceutical, and chemical industry. Many organic
acids are metabolic intermediates, for example, of the tri-
carboxylic acid (TCA) cycle, and therefore can be naturally
produced by a variety of microorganisms. For production in
high amounts, however, metabolic engineering is typically
Abbreviations: OD600, optical density measured at 600 nm; PEP, phosphoenolpyruvate; REF, reference strain; SD, System Duetz; SF, shake flask; TCA,
tricarboxylic acid.
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required. Saccharomyces cerevisiae offers several advantages
for the use as a host for organic acid production such as the
ability to grow at low pH to enable the production of the pro-
tonated acid rather than the salt. The genetic toolbox is well
established, and recent advances enable the efficient genomic
insertion of large DNA fragments as well as deletions ormuta-
tions using the CRISPR-Cas9 system [1–3]. Simultaneous
introduction of multiple genetic modifications (multiplexing)
is also possible [4]. Accordingly, S. cerevisiae has been used
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in a variety of studies to produce organic acids such as malic
acid [5], fumaric acid [6,7], and succinic acid [8–10].
Succinic acid has captured interest as a platform chemi-
cal, and there is plentiful research for its production using
microbial cell factories [11,12]. Besides use as acid, its
value as a precursor for bioplastics and bulk chemicals
such as 1,4-butanediol has attracted much attention [13,14].
Several industrial processes based on different host organisms
have been patented and are used for bio-based succinate pro-
duction [15]. On an industrial scale, S. cerevisiae strains are
being used by Reverdia to produce 10,000 tons of succinate
per year [11]. The market size of succinic acid is expected to
exceed 700,000 tons per annum by 2020, and the estimated
cost of succinic acid made via fermentation ($0.55–$1.10 per
kg) is comparable to the petrochemical route that uses maleic
anhydride as raw material [11,16].
Although S. cerevisiae has already been metabolically
optimized for succinate production, the performance often
suffers from high byproduct formation such as ethanol
and glycerol [9,10,17,18]. So far, the genetic engineering
strategies for succinate production with S. cerevisiae have
been based on either the oxidative or the reductive TCA cycle
route. For production via the oxidative route, Raab and col-
leagues deleted the succinate dehydrogenase genes to restrict
oxidation of succinate to fumarate and the isocitrate dehydro-
genase gene to enable succinate production via the glyoxylate
shunt [10]. This enabled extracellular accumulation of succi-
nate (Table 1), but considerable amounts of ethanol, glycerol,
and acids were also excreted into the production medium.
Ito and colleagues built upon this approach and deleted five
alcohol dehydrogenase genes (ADH1–ADH5) to eliminate
the by-product ethanol [18]. This significantly reduced but
did not cease ethanol formation while glycerol formation was
also observed. Accumulation of these byproducts was also
mentioned in another study that enabled succinate production
via the deletion of mitochondrial malate transport [9]. Fur-
ther studies have engineered strains for succinate production
via the reductive arm of the TCA cycle, which includes
carbon dioxide fixation and offers higher product yield in
comparison to the oxidative route [19]. Yan and colleagues
engineered the reductive pathway in a strain (TAM), which
lacks the pyruvate decarboxylase genes and is incapable of
ethanol production [20]. This strain also had previously been
evolved to be independent of the requirement of a C2 carbon
source (e.g., acetate or ethanol) and does not exhibit glucose
sensitivity, both of which are characteristics associated with
pyruvate decarboxylase deletion mutants [21,22]. As the
TAM strain also accumulates pyruvate, which can be reduced
to succinate (Figure 1), it is a reasonable basis strain for
succinate production. It is worth mentioning that there are
several patents reporting very high titers for succinate with
strains similarly engineered to those mentioned above and in
this study. However, details such as growth characteristics,
PRACTICAL APPLICATION
We explored the use of a pyruvate decarboxylase-
negative and pyruvate accumulating Saccharomyces
cerevisiae strain for succinate production employ-
ing the reductive tricarboxylic acid (TCA) cycle.
Compared with the oxidative branch of the TCA
cycle and the glyoxylate shunt, this route allows a
higher theoretical product yield on glucose. How-
ever, it is only superior when NADH availabil-
ity required for the reductive steps is abundant.
Here we show that NADH is limiting and that
reducing competition for this crucial cofactor with
the respiratory chain and increasing its formation
by formate oxidation improves succinate synthe-
sis. Moreover, an efficient drain of pyruvate into
the reductive arm of the TCA requires high pyru-
vate carboxylase activity. This was achieved here
by increasing the copy number of chromosomally
integrated PYC2 genes using a transposon-sequence-
based strategy resulting in significantly boosted
succinate production. These findings are of practical
relevance for future efforts to engineer S. cerevisiae
strains for dicarboxylic acid synthesis.
process set-up, byproduct formation, and their concentrations
are often missing.
In this study, we exploited the potential of the TAM strain.
We overexpressed (heterologous) genes for the carboxylation
and further reduction of pyruvate to succinate and its export.
In addition, we addressed redox cofactor supply and the enzy-
matic bottleneck of pyruvate carboxylation.
2 MATERIALS AND METHODS
2.1 Integration of the succinate production
pathway
The strains and plasmids used in this study are listed in
Table 2. For the implementation of the reductive succinate
production pathway, six different plasmids carrying the genes
pckA, PYC2, MDH3, fumC, FRDS1, and mae1 were synthe-
sized and the gene cassettes integrated into the yeast genome.
Each gene cassette was equipped with a distinct promoter and
terminator (Figure 1B). The promoter sequences consisted
of at least 400 bp upstream, whereas terminator sequences
were generally 225 bp downstream of the corresponding
genes. The sequences of the heterologous genes were codon-
optimized for expression in S. cerevisiae. All sequences are
provided in the Supporting Information. The promoters were
ZAHOOR ET AL. 713











AH22ura3 ∆sdh2∆sdh1∆idh1∆idp1 3.6 0.11 0.02 [10]
PMCFfg 9.98 0.32 0.14 [8]
8D evolved + pICL1 0.9 0.03 – [53]
S149sdh12 with mae1 0.41 0.03 0.19 0.01 [18]
∆dic1 0.23 0.02 0.4 – [9]





































Promoter Gene Organism Terminator
PPGK1 PYC2 S. cerevisiae TPGK1
PENO2 pckA M. succiniciproducens TENO2
PTPI1 MDH3 S. cerevisiae TADH1
PTDH3 fumC E. coli TCYC1
PTEF1 FRDS1 S. cerevisiae TTDH1
PTEF2 mae1 S. pombe TENO1
A
B
F IGURE 1 (A) A schematic depiction of the central carbon
metabolism of S. cerevisiae and the metabolic engineering approach
used in this study. The two carbon dioxide fixation reactions convert
either PEP or pyruvate into oxaloacetate, which is then reduced in three
further steps to succinate and finally exported outside of the cell by a
heterologous transporter (Mae). (B) Description of the pathway genes
and the donor organisms as well as the regulatory elements (all from
S. cerevisiae) used for the construction of the integrated gene cassettes
selected for constitutive expression in S. cerevisiae based
on previous studies [23,24]. Except for PYC2 (which was
cloned into pCfb255), all cassettes were synthesized and
sequenced by Thermo Fisher Scientific. From the plasmids,
each cassette was amplified using primers carrying a 60 bp
homologous sequence with the amplification primer of the
cassette it was to be recombined with [1]. The first and last
cassettes additionally carried sequences homologous to the
X2 insertion site on the genome as well as the selection
marker (KlURA3) [25]. The amplified gene cassettes were
transformed into yeast cells, and genomic integration was
confirmed by colony PCR [26].
2.2 CRISPR/Cas9 mediated deletion of GPD1
and LEU2
A CRISPR/Cas9 toolset was used for the deletion of GPD1
and LEU2 [3]. AlthoughGPD1was deleted to reduce the loss
of carbon and reduced cofactors in the glycerol formation
pathway, LEU deficiency was required for the multi-copy
integration of PYC2, for which LEU2 was used as a selection
marker. The CRISPR/Cas9 toolset consisted of two plas-
mids: pCfB2312 carried the Cas9 endonuclease and was
transformed in combination with pCfB3496, which carried
the gRNA for the desired locus and a repair oligo comple-
mentary to sequences up- and downstream of the locus to
be deleted. gRNA and repair oligos were designed using
the web-based tool yeastriction [4]. The colonies obtained
after transformation were tested for successful deletion using
colony PCR. Plasmid curing was achieved by streaking the
clones on YEP agar plates without antibiotics. Plasmid loss
was confirmed by the inability of clones to grow on medium
with antibiotics.
2.3 KanMX resistance cassette mediated
FUM1 deletion
For deletion of FUM1, a KanMX resistance cassette was
amplified with 600 bp overhangs containing sequences
homologous to the upstream and downstream regions of the
FUM1 gene [27]. This DNA fragment was transformed into
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TABLE 2 List of strains and plasmids used in this study
Strain Description Reference
REF S. cerevisiae CEN.PK 111–61A. MAT𝛼 ura3-52 leu2-112 his3-Δ1 Euroscarf
REF-5 REF with genomic insertion of PYC2-PCKA-MDH3-FUMC-FRDS1 pathway This study
REF-6 REF with genomic insertion of PYC2-PCKA-MDH3-FUMC-FRDS1-MAE1 pathway This study
TAM S. cerevisiaeMATa pdc1(−6,−2)::loxP pdc5(−6,−2)::loxP pdc6(−6,−2)::loxP ura3-52 [20]
TAM-5 TAM with genomic insertion of PYC2-PCKA-MDH3-FUMC-FRDS1 pathway This study
TAM-6 TAM with genomic insertion of PYC2-PCKA-MDH3-FUMC-FRDS1-MAE pathway This study
TAM-6 ∆gpd1 TAM-6 with GPD1 deletion This study
TAM-6 ∆fum1 TAM-6 with FUM1 deletion This study
TAM-6 ∆gpd1 ∆fum1 TAM-6 with GPD1 and FUM1 double deletion This study
FA TAM-6 gpd1∆ fum1∆ leu2∆ This study
FA1 FA with multiple genomic insertion of PYC2 gene-cassette This study
Plasmid
pCfb255 Easyclone integrative vector with loxP flanked URA3 marker. Ampr [25]
pCfb255-PYC2 pCfb255 carrying the PYC2 cassette. Ampr This study
pMK-RQ-pckA Plasmid carrying the pckA cassette. Kanr This study
pMA-RQ-MDH3 Plasmid carrying the MDH3 cassette. Ampr This study
pMK-RQ-fumC Plasmid carrying the fumC cassette. Kanr This study
pMK-RQ-mae1 Plasmid carrying the mae1 cassette. Kanr This study
pMA-FRDS1 Plasmid carrying the FRDS1 cassette. Ampr This study
pCfB2312 CRISPR-Cas9 plasmid carrying the Cas9 endonuclease. KanMXr [34]
pCfB3496 CRISPR-Cas9 plasmid for cloning the gRNA. Hphr [3]
pCfB3496-GPD1 CRISPR-Cas9 plasmid carrying the gRNA for GPD1 This study
pCfB3496-LEU2 CRISPR-Cas9 plasmid carrying the gRNA for LEU2 This study
pCfB2991 pTY1Cons2-KlLEU2-deg. [46]
p2991-PYC2-Ty Plasmid carrying the PYC2 gene-cassette with overhangs homologous to the Ty1Cons2
sites in the genome and a weakened LEU2 marker. Ampr
This study
yeast cells, and deletion of FUM1 was confirmed by the PCR
products obtained using a set of primers binding upstream of
the FUM1 locus and within the KanMX cassette and a PCR
reaction using a primer set binding upstream of the FUM1
locus and within the FUM1 gene.
2.4 Cultivation conditions
The strains were routinely grown at 30◦C either in 500 mL
shake flasks (SFs) filled with 50 mL medium or in 24 deep-
well plates (Enzyscreen, System Duetz®) with a filling vol-
ume of 1.5 mL per well. A shaking speed of 200 rpm in
a rotary shaker (Infors Multitron, Switzerland) with 25 mm
amplitude was used for aerobic cultivations. The shaking
speed was reduced to 90 rpm for microaerobic growth.
Overnight cultures were made by inoculating cells in
YEP medium (1% yeast extract, 1% peptone, 0.5% sodium
chloride, and 2% glucose). For production experiments, the
overnight culture was centrifuged, washed, and re-suspended
in mineral salt medium to a starting OD600 (optical den-
sity measured at 600 nm) of 1. The composition of the
mineral salt medium was as follows: 3 g/L KH2PO4, 0.5 g/L
MgSO4⋅7H2O, 0.4 g/L urea, 6.6 g/L K2SO4, 0.015 g/L
EDTA, 0.0045 g/L CaCl2⋅H20, 0.0045 g/L ZnSO4⋅7H20,
0.003 g/L FeSO4⋅7H20, 0.0003 g/L CuSO4⋅4H2O, 0.001 g/L
MnCl2⋅4H2O, 0.0004 g/L Na2MoO4⋅2H2O, 0.0003 g/L
CoCl2⋅6H2O, 0.001 g/L H3BO3, and 0.0001 g/L KI. Vitamins
were added at a final concentration of: 0.25 g/L myo-inositol,
0.01 g/L nicotinic acid, 0.01 g/L pyridoxine-HCl, 0.01 g/L
thiamin-HCl, 0.0005 g/L biotin, 0.01 g/L calcium pantothen-
ate, and 0.002 g/L p-aminobenzoic acid [8]. The medium was
routinely buffered with 30 g/L of calcium carbonate, and 5%
glucose was used as a substrate.
2.5 Analytical methods
All SF cultivation experiments were performed in triplicates.
The data shown are the arithmetic mean of the triplicates with
the corresponding standard deviations.When calcium carbon-
ate (CaCO3) was used as a buffer, the samples were treated
with concentrated hydrochloric acid (HCl) prior to measuring
the optical density (OD600) or running HPLC analysis. One
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milliliter of culture was mixed with 400 µL of concentrated
HCl and 600 µL water to dissolve the CaCO3 completely. The
OD600 was measured using an Ultrospec 10 cell density meter
(Amersham Biosciences, UK) and converted to biomass con-
centrations using a conversion factor of 0.21 gCDW/L per
OD600 previously determined by Czarnotta et al. [28].
HPLC was used to quantify extracellular metabolites from
acidified supernatant of culture samples. The HPLC system
(Beckman Coulter, Brea) was equipped with a UV detector
(Beckman Coulter, Brea) set to a wavelength of 210 nm, and
a refractive index detector operated at 40◦C (Knauer, Ger-
many). Analyte separation was achieved with an Organic Acid
Resin column (CS Chromatographie, Germany) eluted with
30 mM sulfuric acid containing 1% (v/v) acetonitrile using an
isocratic flow of 0.6 mL/min.
3 RESULTS AND DISCUSSION
3.1 Design of the recombinant succinate
synthesis pathway
We expressed the genes for the anaplerotic enzymes pyruvate
carboxylase and phosphoenolpyruvate carboxykinase, the
genes for the reductive TCA cycle enzymes malate dehy-
drogenase, fumarase, and fumarate reductase as well as a
gene encoding a malic acid transporter to enable succinate
production and export. One of the challenges was enabling
cytosolic expression of all these reactions because not all of
them exist naturally in S. cerevisiae, proceed in the reversed
direction or are localized to another compartment. Hence,
genes were expressed heterologously to have a complete
pathway, and native genes were modified to be localized in
the cytosol instead of in the mitochondrion.
Phosphoenolpyruvate (PEP) carboxykinase from the nat-
ural succinate producer Mannheimia succiniciproducens
(encoded by pckA) (EC 4.1.1.49) was chosen for the con-
version of PEP to oxaloacetate. The PEP carboxykinase has
been shown to be the most crucial carbon dioxide-fixing reac-
tion for succinate production in this strain [29]. Addition-
ally, its expression in a eukaryotic host has been documented
to improve succinate formation [30]. The second anaplerotic
reaction was the pyruvate carboxylase (EC 6.4.1.1) encoded
by S. cerevisiae’s native PYC2 gene. Because the TAM strain
accumulates pyruvate, overexpression of the native pyruvate
carboxylase should enable pyruvate conversion to oxaloac-
etate and eventually to succinate with the downstream path-
way enzymes. S. cerevisiae possesses three malate dehy-
drogenases (EC 1.1.1.37) responsible for NADH-dependent
OAA reduction to malate. MDH3 encoding the peroxisomal
isozyme was chosen as the cytosolic form (Mdh2) is repressed
by glucose [31]. Mdh3 was relocalized to the cytosol by
removing the peroxisomal targeting sequence as previously
reported by Yan et al. [8]. Fumarase (EC 4.2.1.2) catalyzes
the reversible hydration/dehydration of fumarate to malate.
In S. cerevisiae, the fumarase is known to function in the
direction of fumarate hydration to malate [32] and is located
both in the cytoplasm and the mitochondria [33]. Cytoplas-
mic conversion of malate to fumarate was achieved by expres-
sion of the Escherichia coli fumarase gene fumC [34]. The
last step in the pathway is catalyzed by the native cytoso-
lic fumarate reductase, encoded by FRDS1, which was over-
expressed. Export of succinate was enabled by heterologous
expression of mae1, encoding a Schizosaccharomyces pombe
malic acid transporter, known to reversible transport malate
as well as similar dicarboxylic acids such as succinate and
fumarate [18,35].
3.2 Chromosomal expression of the
heterologous pathways in the wild-type
and TAM strain
The above-described pathway was integrated into the genome
of the S. cerevisiae CEN.PK reference strain (designated as
REF) and the pyruvate decarboxylase mutant TAM either
completely (six-step pathway) or excluding the Mae1 trans-
porter (five-step pathway) [20]. The strains were grown in a
mineral salt medium under microaerobic conditions by set-
ting the shaking frequency to 90 rpm. Growth was followed
by measuring OD600, and culture supernatants were analyzed
for organic acid production. The TAM strain reached a higher
OD600 (28 ± 0) compared to the REF (18 ± 1). Integration
of the five-step pathway into the TAM strain (TAM-5) did
not affect the final biomass concentration, but the six-step
pathway reduced it by approximately 30% to an OD600 of
20 (Figure 2). Conversely, expression of both the five- and
six-step (REF-5 and REF-6) pathways had a positive effect on
biomass formation of the wild-type strain and the final OD600
increased by almost 18% and 17%, respectively. Interestingly,
the TAM strain was capable of producing succinate even
without expressing the pathway genes and accumulated
approximately 0.5 g/L succinate. The same titer was observed
with the five-step pathway. In contrast, succinate production
with the wildtype was only observed after integration of
the succinate synthesis pathways. The expression of the
mae1 gene was critical in both strain backgrounds and
led to an almost three times higher succinate titer in the
wildtype (REF-6) and a twofold increase in the TAM
strain (TAM-6) compared with the strains carrying the
succinate synthesis pathway but lacking the transporter.
In several other studies, introduction of a heterologous
transporter function has been shown to be critical for
the extracellular accumulation of several organic acids
including succinate [5,18,36]
The TAM strain did not produce ethanol, the main by-
product formed by the wild-type strain in concentrations as
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F IGURE 2 Comparison of the reference and TAM strains
engineered for succinate production. The strains were cultivated in
mineral salt medium with 5% glucose as substrate and supplemented
with 22 mM formate under microaerobic conditions (shaking frequency
90 rpm). Data presented are the mean and standard deviation of
triplicate samples taken at 144 h
high as 18 g/L, but similar amounts of pyruvate. Although
pyruvate titers decreased in the engineered strains, the contin-
uing accumulation of this precursor indicated a limitation in
the downstream succinate pathway. Nevertheless, the higher
product titer and the absent formation of ethanol suggested
the TAM strain to be a better chassis for succinate production
compared with the reference strain.
3.3 Effect of GPD1 and FUM1 deletion
on product titers
Glycerol was the second major by-product produced by the
TAM strains and constituted a considerable carbon loss (3–
6% w/w, Table 3). Furthermore, it is known that the fumarase
of S. cerevisiae functions primarily in the oxidative direction,
whereas for the pathway designed in this study a function in
the reverse direction is desired (Figure 1) [32]. Accordingly,
we aimed to delete these activities, singly and in combina-
tion, in the TAM strain carrying the six-step pathway (TAM-
6). The generated strains were grown in mineral salt medium,
and their growth, as well as organic acid production, was ana-
lyzed. Deletion of glycerol phosphate dehydrogenase encod-
ing GPD1 did not significantly impact the biomass forma-
tion, whereas the deletion of fumarase reduced it by approxi-
mately 14%; the double deletion mutant also showed a similar
growth deficiency (Table 3). Single as well as double deletion
ofGPD1 and FUM1 resulted in an increased malate and pyru-
vate titer while the succinate titer increased only in the double
knockout mutant and a maximal titer of 2.2 g/L was deter-
mined, an almost 2.5-fold improvement compared with the
TAM-6 strain. Intriguingly, the glycerol titer increased in the
strains deficient in FUM1 and was not completely abolished
by GPD1 deletion (Table 3). Residual glycerol formation was
also observed byYan et al. and is explained by theGPD1 para-
logGPD2 [8]. The additional deletion ofGPD2was, however,
not considered as it results in an osmosensitive phenotype and
renders cells incapable of anaerobic growth [37].
The microaerobic cultivation conditions applied in these
experiments favored the production of the reduced byproduct
glycerol [38]. Indeed, shaking at a higher frequency (200 rpm)
resulted in cessation of glycerol synthesis in the TAM-6
gpd1∆ fum1∆ strain but also stopped succinate production
(data not shown). Apparently, the introduced succinic acid
pathway could not compete with the native glycerol synthesis
pathways or respiratory chain for the reduced cofactor NADH,
or the (recombinant) enzyme activity was limiting the reduc-
tion of oxaloacetate to succinate. Weakening GPD2 expres-
sion, for example, by promoter exchange, might be helpful to
minimize glycerol production and redirect flux toward suc-
cinic acid production while avoiding the negative effects asso-
ciated with complete glycerol dehydrogenase deficiency.
3.4 Effect of oxygen limitation and formate
supplementation on succinate production by
TAM-6 gpd1∆ fum1∆
To further test if NADH availability limited succinate produc-
tion in the best producing strain, TAM-6 gpd1∆ fum1∆, we
modulated the oxygen transfer rate by changing the shaking
frequency and adding formate (22 mM) to the medium.While
O2 limitation reduces competition for NADH oxidation with
the NADH dehydrogenases of the respiratory chain, the
oxidation of formate to CO2 results in NADH formation
and hence increased redox cofactor supply [39]. As the
two formate dehydrogenase genes (FDH1 and FDH2) in S.
cerevisiae are induced by formate, no additional strain engi-
neering was done to test the impact of adding this additional
energy source [40]. The experiments were carried out in SFs
or System Duetz (SD) 24-well microplates, which enabled a
higher throughput compared to flasks. The strain was grown
in mineral salt medium with 5% glucose, and the succinate
production under the above-mentioned conditions was studied
(Figure 3). In SFs, formate supplementation improved suc-
cinate titer (+21%) as well as yield on glucose (+78%).
Conversely, growth was slower, resulting in decreased
productivity. Oxygen limitation, realized by shaking at
90 rpm, had a positive influence on succinate production and
increased titer, yield, as well as productivity by +32%, +68%,
and +25%, respectively. Oxygen limitation in SD cultivations
resulted in a more pronounced improvement with succinate
titer, productivity, and yield increased by +150%, +80%, and
+170%, respectively. Use of a higher starting OD600 of 10
(SD 90 F’, Figure 3) yielded the highest succinate titer (3 g/L)
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TABLE 3 Growth, organic acid, and glycerol formation by the engineered strains. Strains were cultivated in SD deep-well plate and shaken at
90 rpm. Mineral salt medium with 50 g/L glucose and 22 mM formate was used. The data presented are the mean and standard deviation of triplicate
samples taken after 144 h
g/L
Strain OD600 Malate Pyruvate Succinate Glycerol
TAM 28.3 ± 0.2 0.3 ± 0.0 13.6 ± 0.1 0.5 ± 0.0 3.1 ± 0.5
TAM-6 19.5 ± 1.1 0.4 ± 0.0 9.3 ± 0.3 0.9 ± 0.1 1.4 ± 0.7
TAM-6 gpd1∆ 20.5 ± 2.5 0.8 ± 0.0 13.9 ± 1.7 0.8 ± 0.1 2.2 ± 0.8
TAM-6 fum1∆ 16.7 ± 0.9 0.7 ± 0.0 14.2 ± 5.1 1.1 ± 0.1 6.7 ± 0.7
TAM-6 gpd1∆ fum1∆ 15.3 ± 1.5 1.1 ± 0.0 18.2 ± 0.4 2.2 ± 0.1 3.8 ± 0.3
F IGURE 3 Effect of formate supplementation and oxygen
limitation on succinate production in the TAM-6 gpd1∆ fum1∆ strain
in SFs and SD. The numeric value after the SF/SD depicts the shaking
frequency (in rpm), F stands for formate supplementation. F’ represents
the experiment with higher starting biomass concentration (OD600 of
10). The data are the mean of triplicate experiments; error bars show
the standard deviation
in this study and further improved yield (+33%), whereas the
specific productivity was reduced (–22%).
The different performance in the two cultivation settings
might be explained by differences in the oxygen transfer rate,
which according to Meier et al. is much lower in SFs at the
set frequency of 90 rpm, potentially too low to sustain opti-
mal ATP formation and succinate production [41]. A more
in-depth study of the dependence of succinate synthesis on
oxygen availability might be valuable to improve production
further.
A similar positive impact of NADH availability on organic
acid biosynthesis has been reported previously for S. cere-
visiae as well as Yarrowia lipolytica [42,43]. Also, it has
been shown that under anaerobic conditions, the intracellular
concentration of succinate and other TCA cycle intermedi-
ates is higher compared to their concentration under aerobic
growth [44]. Lifting redox cofactor limitations by oxidation
of formate has also successfully been applied for succinate
synthesis in Corynebacterium glutamicum. Heterologous
expression of formate dehydrogenase in the engineered strain
improved succinate yield by more than 20% [45]. Although
formate addition resulted in increased succinate synthesis
in our studies as well, we also observed glycerol formation
in cultures grown at reduced shaking frequency and with
formate supplementation (data not shown). The secretion of
this reduced by-product indicates that under this condition the
reductive succinate synthesis pathway can either not fully oxi-
dize the NADH due to enzymatic limitations or not efficiently
compete with the residual glycerol dehydrogenase activity.
3.5 Multiple genomic integrations
of the pyruvate carboxylase (PYC2) cassette
The engineered yeast strain still accumulated a significant
amount of pyruvate also under optimized conditions (Table 3)
further supporting the hypothesized enzymatic bottleneck in
the succinate biosynthesis pathway. To resolve this poten-
tial limitation, multiple copies of the pyruvate carboxylase
gene were integrated into the genome of strain TAM-6 gpd1∆
fum1∆ by targeting Ty retrotransposon elements [46]. As
many as 331 Ty insertions have been identified, spread across
the S. cerevisiae genome of strain S288c [47]. These sites are
attractive for multiple genomic integrations of heterologous
DNA (Figure 1), which has been used to tackle metabolic bot-
tlenecks and improve production [11,48,49].We did not quan-
tify the number of PYC2 copies integrated into the genome
but assume similar copy numbers as reported by Borodina and
coworkers [48,50], that is, in the range of 2–4 copies.
Multi-copy integration of the PYC gene resulted in growth
deficiency under oxygen-limiting conditions (see the Sup-
porting Information). We hypothesized that this growth defect
was caused by a limited supply of ATP for cellular processes
under those microaerobic conditions caused by increased con-
sumption of ATP for pyruvate carboxylation. Indeed, shaking
at higher rpm relieved the growth suppression, and the strain
(FA1) grew as well as the parental strain (TAM-6 gpd1∆
fum1∆) and importantly produced three times less pyruvate.
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F IGURE 4 Two-stage cultivation of the strains TAM-6 gpd1∆
fum1∆ (A) and FA1 (B). Cultivation was carried out at 300 rpm for the
first 48 h (dotted line) and then switched to 90 rpm to enable optimal
organic acid production
To achieve a compromise between growth deficiency of
FA1 and optimal succinate production under oxygen-limiting
conditions, a two-stage production approach was followed.
During the first stage, the strain was grown at 300 rpm for 48 h
to enable efficient biomass formation; afterward, the shaking
speed was reduced to 90 rpm for efficient succinate produc-
tion (Figure 4). For comparison, strain TAM-6 gpd1∆ fum1∆
was also cultivated under the same conditions and growth
as well as organic acid production were regularly monitored
(Figure 4). Both strains merely produced carboxylic acid
during the aerobic growth phase, but instead accumulated
pyruvate, which was consumed after glucose depletion
and converted to succinate, oxaloacetate, and malate. The
FA1 stain produced almost 40% less pyruvate and reached
a more than 2.5 times higher succinate titer (2 g/L) and
specific productivity (maximum of 7 mg/gCDW/h in the initial
nongrowing production stage) than its parental strain culti-
vated under the same conditions. Simultaneously an increase
of almost 80% and 62% was noted for the oxaloacetate and
malate titer compared to the parental strain.
Compared to another engineered TAM strain grown under
similar conditions [8], FA1 produced nearly three times less
pyruvate. This highlights the effectiveness of the multicopy
integration of the pyruvate carboxylase cassette to channel
more pyruvate into the reductive arm of the TCA cycle. How-
ever, the secretion of the succinate precursors oxaloacetate
and malate points to additional enzymatic limitations as well
as the high affinity of the Mae1 exporter for malate.
In addition to strain engineering, this study also empha-
sizes the importance of process engineering. Improved pro-
duction of succinate and utilization of accumulated pyruvate
was achieved when a two-stage concept was applied, in which
an initial aerobic growth phase was followed by an oxygen-
limited production phase. Such a decoupling of growth and
production has also been shown to be of relevance for high-
level succinate production via the reductive arm of the TCA
cycle in engineered E. coli strains [51,52].
Vemuri and colleagues showed that for the dual-phase
fermentation, the transition time of the culture from growth
to production phase has a significant effect on succinate
accumulation and that highest succinate productivity is
achieved when the aerobic phase takes place at a medium
oxygen-transfer rate [52]. Although out of scope of this
study, a detailed bioprocess optimization including the shift
between the two stages will be critical to further develop the
S. cerevisiae-based process toward high titers, yields, and
rates.
4 CONCLUDING REMARKS
We have elucidated potential metabolic bottlenecks in engi-
neered S. cerevisiae limiting efficient succinate production
and report strategies to overcome those drawbacks. Identified
enzymatic and redox cofactor limitations were addressed
by multiple genomic integrations of pyruvate carboxylase
encoding PYC2 and by reducing the oxygen transfer and
hence the activity of competing NADH dehydrogenases
as well as by addition of formate as an auxiliary energy
source. Separation of growth and production proved useful
to sustain the required energy demands for both processes.
A transporter with higher specificity for succinate would
be on our wishlist when working on the next generation
strains. This study contributes to the ongoing discussion on
the production of organic acids in yeasts and the challenges
associated with redox cofactor balancing.
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